SABA KHAN: Open Payments
NPI 1376856187 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 36 payments from 14 companies in 2025. Trend: 2023 $343 · 2024 $1,117 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $149 |
| Novo Nordisk Inc | 8 | $145 |
| Lilly USA, LLC | 3 | $84 |
| AstraZeneca Pharmaceuticals LP | 2 | $56 |
| Gilead Sciences, Inc. | 2 | $50 |
| Exact Sciences Corporation | 2 | $50 |
| Inspire Medical Systems, Inc. | 2 | $48 |
| Indivior Inc. | 2 | $48 |
| Corcept Therapeutics | 2 | $47 |
| Noven Therapeutics, LLC | 2 | $46 |
Products named: VIVITROL, MOUNJARO, AIRSUPRA, Wegovy, Cologuard Collection Kit, INSPIRE, SUBLOCADE, Korlym.
Industry payments across NY — which companies pay providers there.
